Multifaceted cardiac signal transduction mediated by G protein-coupled receptors: Potential target sites where an unambiguous attention is needed for exploring new drugs for cardiovascular disorders

Biomedicine and Aging Pathology

Volumn 1, Issue 4, 2011, Pages 197-202

  Balakumar, Pitchai ^a   Mahadevan, Nanjaian ^a  

^a Rajendra Institute of Technology and Sciences   (India)

Author keywords

arrestin; arrestin biased ligands; CaM kinase II; EGFR; G proteins; GPCR; RGS2

Indexed keywords

ALPRENOLOL; BETA ARRESTIN; CARVEDILOL; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; RGS2 PROTEIN;

CARDIOVASCULAR DISEASE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HYPERTROPHY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 83455261785     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2011.04.004     Document Type: Review

References (83)

1. A.G. Gilman G proteins: transducers of receptor-generated signals Annu Rev Biochem 56 1987 615 649
2. M. Rodbell, M.C. Lin, Y. Salomon, C. Londos, J.P. Harwood, and B.R. Martin Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multisite transition states Adv Cyclic Nucleotide Res 5 1975 3 29
3. W.M. Oldham, and H.E. Hamm Heterotrimeric G protein activation by G-protein-coupled receptors Nat Rev Mol Cell Biol 9 2008 60 71
4. P. Svoboda The Nobel Prize for Physiology and Medicine 1994. Alfred G. Gilman and Martin Rodbell-the role of GTP-binding proteins in signal transfer in the interior of cells Cas Lek Cesk. 134 1995 415 417
5. T.N. Raju The Nobel chronicles. 1994: Alfred G. Gilman (b 1941) and Martin Rodbell (1925-98) Lancet 355 2000 2259
6. R. Fredriksson, M.C. Lagerstrom, L.G. Lundin, and H.B. Schioth The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol Pharmacol 63 2003 1256 1272 (Pubitemid 36627220)
7. M.C. Lagerström, and H.B. Schiöth Structural diversity of G protein-coupled receptors and significance for drug discovery Nat Rev Drug Discov 7 2008 339 357
8. R.P. Millar, and C.L. Newton The year in G protein-coupled receptor research Mol Endocrinol 24 2010 261 274
9. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat Rev Drug Discov 5 2006 993 996 (Pubitemid 44835126)
10. D.M. Harris, H.I. Cohn, S. Pesant, R.H. Zhou, and A.D. Eckhart Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension Am J Physiol Heart Circ Physiol 293 2007 H3072 H3079
11. V. LaMorte, J. Thorburn, D. Absher, A. Spiegel, J. Brown, and K. Chien Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha1-adrenergic stimulation J Biol Chem 269 1994 13490 13496
12. S.A. Akhter, L.M. Luttrell, H.A. Rockman, G. Iaccarino, R.J. Lefkowitz, and W.J. Koch Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy Science 280 1998 574 577 (Pubitemid 28227758)
13. T. Eschenhagen, U. Mende, M. Nose, W. Schmitz, H. Scholz, and A. Haverich Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure Circ Res 70 1992 688 696
14. D.S. Feldman, T.S. Elton, B. Sun, M.M. Martin, and M.T. Ziolo Mechanisms of disease detrimental adrenergic signaling in acute decompensated heart failure Nat Clin Pract Cardiovasc Med 5 2008 208 218 (Pubitemid 351472165)
15. W.M. Oldham, and H.E. Hamm How do receptors activate G proteins? Adv Protein Chem 74 2007 67 93 (Pubitemid 47369747)
16. Y. Fang, J. Lahiri, and L. Picard G protein-coupled receptor microarrays for drug discovery Drug Discov Today 8 2003 755 761 (Pubitemid 37011247)
17. N. Wettschureck, S. Offermanns, and Mammalian G proteins and their cell type specific functions Physiol Rev 85 2005 1159 1204 (Pubitemid 41362268)
18. W.R. Leifert, A.L. Aloia, O. Bucco, and E.J. McMurchie GPCR-induced dissociation of G-protein subunits in early stage signal transduction Mol Membr Biol 22 2005 507 517 (Pubitemid 43030906)
19. G.B. Downes, N. Gautam, and The G protein subunit gene families Genomics 62 1999 544 552
20. A. Spiegel Cell signaling: beta-arrestin-not just for G protein-coupled receptors Science 301 2003 1338 1339 (Pubitemid 37075800)
21. N. Noor, C.B. Patel, and H.A. Rockman β-Arrestin: a signaling molecule and potential therapeutic target for heart failure J Mol Cell Cardiol 2010 10.1016/j.yjmcc.2010.11.005
22. A. Wirth, Z. Benyó, M. Lukasova, B. Leutgeb, N. Wettschureck, and S. Gorbey G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension Nat Med. 14 2008 64 68
23. S.G. Rhee Regulation of phosphoinositide-specific phospholipase C Annu Rev Biochem 70 2001 281 312 (Pubitemid 32662212)
24. A. Gilchrist, A. Li, and H.E. Hamm G alpha COOH-terminal minigene vectors dissect heterotrimeric G protein signaling Sci STKE 2002 118 2002 pl1
25. T.D. Werry, G.F. Wilkinson, and G.B. Willars Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+ Biochem J 374 Pt 2 2003 281 296 (Pubitemid 37094087)
26. T.D. Bunney, and M. Katan PLC regulation: emerging pictures for molecular mechanisms Trends Biochem Sci 2010 10.1016/j.tibs.2010.08.003
27. M. Grimm, and J.H. Brown Beta-adrenergic receptor signaling in the heart: role of CaMKII J Mol Cell Cardiol 48 2010 322 330
28. S. Mishra, H. Ling, M. Grimm, T. Zhang, D.M. Bers, and J.H. Brown Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling J Cardiovasc Pharmacol 2010 [In Press]
29. H. Ling, T. Zhang, L. Pereira, C.K. Means, H. Cheng, and Y. Gu Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice J Clin Invest 119 2009 1230 1240
30. S. Sossalla, N. Fluschnik, H. Schotola, K.R. Ort, S. Neef, and T. Schulte Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium Circ Res 107 2010 1150 1161
31. H. Toko, H. Takahashi, Y. Kayama, T. Oka, T. Minamino, and S. Okada Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy Circulation 122 2010 891 899
32. T.M. Filtz, D.R. Grubb, T.J. McLeod-Dryden, J. Luo, and E.A. Woodcock Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b FASEB J 23 2009 3564 3570
33. E.A. Woodcock, D.R. Grubb, and P. Iliades Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b Curr Drug Targets 11 2010 1032 1040
34. E.W. Sutherland, and T.W. Rall Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles J Biol Chem 232 1958 1077 1091
35. T.W. Rall, E.W. Sutherland, and J. Berthet The relationship of epinephrine and glucagon to liver phosphorylase IV Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates J Biol Chem 224 1957 463 475
36. Y. Chen-Izu, R.P. Xiao, L.T. Izu, H. Cheng, M. Kuschel, and H. Spurgeon G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels Biophys J 79 2000 2547 2556
37. G.S. Baillie, A. Sood, I. McPhee, I. Gall, S.J. Perry, and R.J. Lefkowitz Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi Proc Natl Acad Sci U S A 100 2003 940 945 (Pubitemid 36183934)
38. C.M. Tan, A.E. Brady, H.H. Nickols, Q. Wang, and L.E. Limbird Membrane trafficking of G protein-coupled receptors Annu Rev Pharmacol Toxicol 44 2004 559 609 (Pubitemid 38263853)
39. M.I. Simon, M.P. Strathmann, and N. Gautam Diversity of G proteins in signal transduction Science 252 1991 802 808 (Pubitemid 121000516)
40. B. Nurnberg, T. Gudermann, and G. Schultz Receptors and G proteins as primary components of transmembrane signal transduction. Part 2. G proteins: structure and function J Mol Med 73 1995 123 132
41. H. Kurose Galpha12 and Galpha13 as key regulatory mediator in signal transduction Life Sci 74 2003 155 161 (Pubitemid 37357047)
42. T. Fujii, N. Onohara, Y. Maruyama, S. Tanabe, H. Kobayashi, and M. Fukutomi Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts J Biol Chem 280 2005 23041 23047 (Pubitemid 40853214)
43. N. Suzuki, N. Hajicek, and T. Kozasa Regulation and physiological functions of G12/13-mediated signaling pathways Neurosignals 17 2009 55 70
44. Y. Maruyama, M. Nishida, Y. Sugimoto, S. Tanabe, J.H. Turner, and T. Kozasa Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy Circ Res 91 2002 961 969 (Pubitemid 35375250)
45. D.P. Del Re, S. Miyamoto, and J.H. Brown RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis J Biol Chem 282 2007 8069 8078 (Pubitemid 47093605)
46. S. Fukui, Y. Fukumoto, J. Suzuki, K. Saji, J. Nawata, and S. Tawara Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats J Cardiovasc Pharmacol 51 2008 317 326 (Pubitemid 351450612)
47. P. Balakumar, and G. Jagadeesh Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62 2010 365 383
48. M. Nishida, Y. Sato, A. Uemura, Y. Narita, H. Tozaki-Saitoh, and M. Nakaya P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis EMBO J 27 2008 3104 3115
49. O.A. Coso, H. Teramoto, W.F. Simonds, and J.S. Gutkind Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway J Biol Chem 271 1996 3963 3966 (Pubitemid 26070490)
50. P. Crespo, N. Xu, W.F. Simonds, and J.S. Gutkind Ras-dependent activation of MAP kinase pathway mediated by G-protein beta/gamma subunits Nature 369 1994 418 420 (Pubitemid 24184058)
51. J. Yamauchi, M. Nagao, Y. Kaziro, and H. Itoh Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits J Biol Chem 272 1997 27771 27777 (Pubitemid 27473576)
52. L.R. Stephens, A. Eguinoa, H. Erdjument-Bromage, M. Lui, F. Cooke, and J. Coadwell The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101 Cell 89 1997 105 114 (Pubitemid 27180590)
53. U. Maier, A. Babich, and B. Nurnberg Roles of noncatalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma J Biol Chem 274 1999 29311 29317
54. D.E. Logothetis, Y. Kurachi, J. Galper, E.J. Neer, and D.E. Clapham The beta gamma subunits of GTPbinding proteins activate the muscarinic K+ channel in heart Nature 325 1987 321 326 (Pubitemid 17053169)
55. C. Murga, L. Laguinge, R. Wetzker, A. Cuadrado, and J.S. Gutkind Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinase gamma J Biol Chem 273 1998 19080 19085 (Pubitemid 28366302)
56. S. Krugmann, P.T. Hawkins, N. Pryer, and S. Braselmann Characterizing the interactions between the two subunits of the p101/p110gamma phosphoinositide 3-kinase and their role in the activation of this enzyme by G beta gamma subunits J Biol Chem 274 1999 17152 17158
57. T. Yamazaki, I. Komuro, and Y. Yazaki Signalling pathways for cardiac hypertrophy Cell Signal 10 1998 693 698 (Pubitemid 28520021)
58. A.V. Smrcka G protein betagamma subunits: central mediators of G protein-coupled receptor signaling Cell Mol Life Sci 65 2008 2191 2214
59. L.M. Casey, A.R. Pistner, S.L. Belmonte, D. Migdalovich, O. Stolpnik, and Nwakanma Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure Circ Res 107 2010 532 539
60. M. Völkers, C. Weidenhammer, N. Herzog, G. Qiu, K. Spaich, and F. von Wegner The inotropic peptide betaARKct improves betaAR responsiveness in normal and failing cardiomyocytes through Gbetagamma-mediated L-type calcium current disinhibition Circ Res 2010 10.1161/CIRCRESAHA.110.225201
61. K.K. Jernigan, C.S. Cselenyi, C.A. Thorne, A.J. Hanson, E. Tahinci, and N. Hajicek Gbetagamma activates GSK3 to promote LRP6-mediated beta-catenin transcriptional activity Sci Signal 3 121 2010 ra37
62. P. Balakumar, and G. Jagadeesh Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system J Cardiovasc Pharmacol. 56 2010 570 579
63. T. Wieland, S. Lutz, and P. Chidiac Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system Curr Opin Pharmacol 7 2007 201 207 (Pubitemid 46404739)
64. X. Wang, G. Huang, X. Luo, J.M. Penninger, and S. Muallem Role of regulator of G protein signaling 2 (RGS2) in Ca(2+) oscillations and adaptation of Ca(2+) signaling to reduce excitability of RGS2-/- cells J Biol Chem 279 2004 41642 41649 (Pubitemid 39313608)
65. A. Semplicini, L. Lenzini, M. Sartori, I. Papparella, L.A. Calo, and E. Pagnin Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II J Hypertens 24 2006 1115 1124 (Pubitemid 43772320)
66. C. Nunn, M.X. Zou, A.J. Sobiesiak, A.A. Roy, L.A. Kirshenbaum, and P. Chidiac RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy Cell Signal 22 2010 1231 1239
67. S. Tsang, A.Y. Woo, W. Zhu, and R.P. Xiao Deregulation of RGS2 in cardiovascular diseases Front Biosci (Schol Ed) 2 2010 547 557
68. H. Li, C. He, J. Feng, Y. Zhang, Q. Tang, and Z. Bian Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload Proc Natl Acad Sci U S A 107 2010 13818 13823
69. N.J. Freedman, S.B. Liggett, D.E. Drachmann, G. Pei, M.G. Caron, and R.J. Lefkowitz Phosphorylation and desensitization of the human beta 1-adrenergic receptor: Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase J Biol Chem 270 1995 17953 17961
70. L.M. Luttrell, and R.J. Lefkowitz The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals J Cell Sci 115 Pt 3 2002 455 465 (Pubitemid 34182973)
71. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 2005 512 517
72. C.A. Moore, S.K. Milano, and J.L. Benovic Regulation of receptor trafficking by GRKs and arrestins Annu Rev Physiol 69 2007 451 482 (Pubitemid 46457651)
73. S.J. Perry, G.S. Baillie, T.A. Kohout, I. McPhee, M.M. Magiera, and K.L. Ang Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins Science 298 2002 834 836 (Pubitemid 35231537)
74. C.D. Nelson, S.J. Perry, D.S. Regier, S.M. Prescott, M.K. Topham, and R.J. Lefkowitz Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins Science 315 2007 663 666 (Pubitemid 46214713)
75. W.J. Koch, R.J. Lefkowitz, and H.A. Rockman Functional consequences of altering myocardial adrenergic receptor signaling Annu Rev Physiol 62 2000 237 260 (Pubitemid 30618263)
76. H.A. Rockman, W.J. Koch, C.A. Milano, and R.J. Lefkowitz Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice J Mol Med 74 1996 489 495 (Pubitemid 26306790)
77. J.A. Hata, M.L. Williams, and W.J. Koch Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization J Mol Cell Cardiol 37 2004 11 21 (Pubitemid 38900524)
78. J.R. Keys, and W.J. Koch The adrenergic pathway and heart failure Recent Prog Horm Res 59 2004 13 30 (Pubitemid 41327145)
79. J. Machackova, S.K. Sanganalmath, J. Barta, K.S. Dhalla, and N.S. Dhalla Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity Cardiovasc Toxicol 10 2010 9 16
80. T. Noma, A. Lemaire, S.V. Naga Prasad, L. Barki-Harrington, D.G. Tilley, and J. Chen Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection J Clin Invest 117 2007 2445 2458
81. J.W. Wisler, S.M. DeWire, E.J. Whalen, J.D. Violin, M.T. Drake, and S. Ahn A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling Proc Natl Acad Sci U S A 104 2007 16657 16662 (Pubitemid 350211072)
82. I.M. Kim, D.G. Tilley, J. Chen, N.C. Salazar, E.J. Whalen, and J.D. Violin Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation Proc Natl Acad Sci U S A 105 2008 14555 14560
83. J.D. Violin, S.M. DEwire, D. Yamashita, D.H. Rominger, L. Nguyen, and K. Schiller Selectively engaging [beta]-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance J Pharmacol Exp Ther 335 2010 572 579